Baust John M, Rabin Yoed, Polascik Thomas J, Santucci Kimberly L, Snyder Kristi K, Van Buskirk Robert G, Baust John G
1 CPSI Biotech, Owego, NY, USA.
2 Institute of Biomedical Technology, State University of New York at Binghamton, Binghamton, NY, USA.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818762207. doi: 10.1177/1533033818762207.
Diverse thermal ablative therapies are currently in use for the treatment of cancer. Commonly applied with the intent to cure, these ablative therapies are providing promising success rates similar to and often exceeding "gold standard" approaches. Cancer-curing prospects may be enhanced by deeper understanding of thermal effects on cancer cells and the hosting tissue, including the molecular mechanisms of cancer cell mutations, which enable resistance to therapy. Furthermore, thermal ablative therapies may benefit from recent developments in computer hardware and computation tools for planning, monitoring, visualization, and education.
Recent discoveries in cancer cell resistance to destruction by apoptosis, autophagy, and necrosis are now providing an understanding of the strategies used by cancer cells to avoid destruction by immunologic surveillance. Further, these discoveries are now providing insight into the success of the diverse types of ablative therapies utilized in the clinical arena today and into how they directly and indirectly overcome many of the cancers' defensive strategies. Additionally, the manner in which minimally invasive thermal therapy is enabled by imaging, which facilitates anatomical features reconstruction, insertion guidance of thermal probes, and strategic placement of thermal sensors, plays a critical role in the delivery of effective ablative treatment.
The thermal techniques discussed include radiofrequency, microwave, high-intensity focused ultrasound, laser, and cryosurgery. Also discussed is the development of thermal adjunctive therapies-the combination of drug and thermal treatments-which provide new and more effective combinatorial physical and molecular-based approaches for treating various cancers. Finally, advanced computational and planning tools are also discussed.
This review lays out the various molecular adaptive mechanisms-the hallmarks of cancer-responsible for therapeutic resistance, on one hand, and how various ablative therapies, including both heating- and freezing-based strategies, overcome many of cancer's defenses, on the other hand, thereby enhancing the potential for curative approaches for various cancers.
目前多种热消融疗法用于癌症治疗。这些消融疗法通常旨在治愈疾病,其成功率令人鼓舞,与“金标准”方法相当,且常常超过后者。深入了解热对癌细胞及宿主组织的影响,包括癌细胞突变的分子机制(这些机制使癌细胞产生抗药性),可能会提高癌症治愈的前景。此外,热消融疗法可能受益于计算机硬件及计算工具在治疗规划、监测、可视化及培训方面的最新进展。
近期关于癌细胞对凋亡、自噬和坏死破坏产生抗性的发现,使人们了解了癌细胞用于逃避免疫监视破坏的策略。此外,这些发现还让人们深入了解了当今临床领域使用的各种消融疗法的成功之处,以及它们如何直接和间接克服癌症的许多防御策略。另外,成像技术在微创热疗中发挥着关键作用,它有助于重建解剖结构、引导热探针插入以及战略性放置热传感器,从而实现有效的消融治疗。
所讨论的热技术包括射频、微波、高强度聚焦超声、激光和冷冻手术。还讨论了热辅助疗法的发展——药物与热疗相结合——为治疗各种癌症提供了新的、更有效的基于物理和分子的联合方法。最后,还讨论了先进的计算和规划工具。
本综述一方面阐述了导致治疗抗性的各种分子适应性机制——癌症的标志,另一方面阐述了各种消融疗法,包括基于加热和冷冻的策略,如何克服癌症的许多防御机制,从而提高各种癌症治愈方法的潜力。